Logo image of RIME

ALGORHYTHM HOLDINGS INC (RIME) Stock Fundamental Analysis

NASDAQ:RIME - Nasdaq - US8293224031 - Common Stock - Currency: USD

2.77  -0.11 (-3.82%)

After market: 2.71 -0.06 (-2.17%)

Fundamental Rating

1

Taking everything into account, RIME scores 1 out of 10 in our fundamental rating. RIME was compared to 67 industry peers in the Household Durables industry. RIME may be in some trouble as it scores bad on both profitability and health. RIME is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RIME has reported negative net income.
RIME had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RIME reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: RIME reported negative operating cash flow in multiple years.
RIME Yearly Net Income VS EBIT VS OCF VS FCFRIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

The Return On Assets of RIME (-57.75%) is worse than 95.38% of its industry peers.
RIME's Return On Equity of -392.34% is on the low side compared to the rest of the industry. RIME is outperformed by 96.92% of its industry peers.
Industry RankSector Rank
ROA -57.75%
ROE -392.34%
ROIC N/A
ROA(3y)-4.64%
ROA(5y)-5.19%
ROE(3y)-5.06%
ROE(5y)-11.61%
ROIC(3y)N/A
ROIC(5y)N/A
RIME Yearly ROA, ROE, ROICRIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

RIME has a Gross Margin of 18.40%. This is amonst the worse of the industry: RIME underperforms 83.08% of its industry peers.
In the last couple of years the Gross Margin of RIME has declined.
RIME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.32%
GM growth 5Y-1.88%
RIME Yearly Profit, Operating, Gross MarginsRIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RIME has been increased compared to 1 year ago.
Compared to 5 years ago, RIME has less shares outstanding
RIME has a better debt/assets ratio than last year.
RIME Yearly Shares OutstandingRIME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
RIME Yearly Total Debt VS Total AssetsRIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -2.77, we must say that RIME is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RIME (-2.77) is worse than 90.77% of its industry peers.
RIME has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
RIME has a Debt to Equity ratio (0.24) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -2.77
ROIC/WACCN/A
WACC12.72%
RIME Yearly LT Debt VS Equity VS FCFRIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

RIME has a Current Ratio of 0.87. This is a bad value and indicates that RIME is not financially healthy enough and could expect problems in meeting its short term obligations.
RIME's Current ratio of 0.87 is on the low side compared to the rest of the industry. RIME is outperformed by 93.85% of its industry peers.
A Quick Ratio of 0.43 indicates that RIME may have some problems paying its short term obligations.
RIME's Quick ratio of 0.43 is on the low side compared to the rest of the industry. RIME is outperformed by 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.43
RIME Yearly Current Assets VS Current LiabilitesRIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

RIME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.27%, which is quite impressive.
Looking at the last year, RIME shows a very negative growth in Revenue. The Revenue has decreased by -10.05% in the last year.
RIME shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.36% yearly.
EPS 1Y (TTM)20.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.45%
Revenue 1Y (TTM)-10.05%
Revenue growth 3Y0.69%
Revenue growth 5Y-8.36%
Sales Q2Q%-33.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y594.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.22%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RIME Yearly Revenue VS EstimatesRIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RIME Yearly EPS VS EstimatesRIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RIME. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 0.34, which indicates a rather cheap valuation of RIME.
Based on the Price/Forward Earnings ratio, RIME is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.68. RIME is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.34
RIME Price Earnings VS Forward Price EarningsRIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIME Per share dataRIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

RIME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RIME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (2/21/2025, 8:00:01 PM)

After market: 2.71 -0.06 (-2.17%)

2.77

-0.11 (-3.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners2.76%
Inst Owner ChangeN/A
Ins Owners2%
Ins Owner ChangeN/A
Market Cap6.59M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)19900%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.34
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 2.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.75
EYN/A
EPS(NY)8.16
Fwd EY294.58%
FCF(TTM)-2.33
FCFYN/A
OCF(TTM)-2.31
OCFYN/A
SpS10.98
BVpS1.21
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.75%
ROE -392.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.4%
FCFM N/A
ROA(3y)-4.64%
ROA(5y)-5.19%
ROE(3y)-5.06%
ROE(5y)-11.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.32%
GM growth 5Y-1.88%
F-Score2
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.59%
Cap/Sales 0.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.43
Altman-Z -2.77
F-Score2
WACC12.72%
ROIC/WACCN/A
Cap/Depr(3y)73%
Cap/Depr(5y)104.63%
Cap/Sales(3y)0.43%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.45%
EPS Next Y594.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.05%
Revenue growth 3Y0.69%
Revenue growth 5Y-8.36%
Sales Q2Q%-33.32%
Revenue Next Year1.22%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.18%
OCF growth 3YN/A
OCF growth 5YN/A